Moderna stock is under pressure, again, as Robert F. Kennedy Jr. reportedly mulls pulling the company's federal funding to ...

A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological disorder. The phase 3 study is evaluating the candidate, dubbed mRNA-1403 ...

In an early clinical trial, an experimental norovirus vaccine given as a pill produced defensive responses exactly where it counts—in the saliva of older people most vulnerable to the explosive ...

Norovirus has torn through the U.S. this winter, peaking early in some parts of the country but taking hold in South Florida ...

Moderna reports larger-than-expected quarterly loss Revenue falls 66% but beats expectations FDA pauses norovirus vaccine trial after adverse event report Feb 14 (Reuters) - Moderna (MRNA.O ...

Four-year results of a phase III trial showed that budesonide oral suspension (Eohilia) for eosinophilic esophagitis was well-tolerated, with about half of patients achieving or maintaining a ...

This method is simpler to execute and can be more easily updated as different strains of norovirus become dominant, Fink says. His team at Moderna designed an mRNA norovirus vaccine, and the ...

safety and immunogenicity of Moderna’s trivalent vaccine against norovirus is fully enrolled in the Northern Hemisphere and the company is preparing second season enrollment in the Southern ...

HEALTH chiefs have warned winter “is certainly not over” with norovirus hospitalisations still close to record highs – and ...

There is no antiviral treatment for norovirus, and while there isn’t currently a vaccine, drug manufacturer Moderna is working on one. Any norovirus vaccine would require an educated guess as to ...

(Reuters) -Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a rare neurological side effect was reported. The trial of the ...